Literature DB >> 25550094

Factors predicting secondary displacement after non-operative treatment of undisplaced femoral neck fractures.

Mohy E Taha1, Laurent Audigé2, Gregor Siegel3, Nikolaus Renner4.   

Abstract

INTRODUCTION: We quantified the risk and the time of occurrence of secondary fracture displacement in non-operatively treated femoral neck fractures in our clinic, as well as investigated potential predicting patient- and fracture-related factors.
METHODS: The records of 593 patients with femoral neck fractures from January 2000 to December 2009 were reviewed. Sixty-one patients [mean age 83.0 years (SD 9.9)] with undisplaced femoral neck fractures initially received non-operative treatment. The occurrence and the time of secondary fracture displacement were documented, as well as demographics and radiological parameters. Radiographs were evaluated independently by two surgeons. Multivariable regression and Kaplan-Meier survival analyses were used.
RESULTS: Thirty-four (55.7 %) fractures showed secondary displacement occurring within the first 12 weeks after initiation of non-operative treatment. Twenty (38 %) fractures originally classified as Garden I were found to be Garden II. The risk of secondary displacement was three times higher (RR = 2.8; 95 % CI 1.7-4.8, p < 0.001) for these fractures in comparison with those confirmed as Garden I. Patients with a history of previously diagnosed osteoporosis were at a higher risk of secondary displacement as well (RR = 1.3; 95 % CI 1.0-1.5).
CONCLUSIONS: Non-operative treatment of femoral neck fractures is a treatment option, but only in well-selected cases. The majority of secondary displacements were associated with initial misdiagnosis using the Garden classification. For Garden II, primary surgical treatment is likely a better option, and therefore careful application of the Garden classification in this context is essential.

Entities:  

Mesh:

Year:  2014        PMID: 25550094     DOI: 10.1007/s00402-014-2139-9

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  7 in total

1.  Is percutaneous screw fixation really superior to non-operative management after valgus-impacted femoral neck fracture: a retrospective cohort study.

Authors:  L Henry Goodnough; Harsh Wadhwa; Andrew T Fithian; Malcolm R DeBaun; Sean T Campbell; Michael J Gardner; Julius A Bishop
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-07-24

2.  [Research progress in treatment of femoral neck fracture in the elderly].

Authors:  Yangyang Zhou; Yingjie Ni; Xingjuan Li; Hui Chen; Yunfeng Rui
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-08-15

Review 3.  Recommendations on hip fractures.

Authors:  K Wendt; D Heim; C Josten; R Kdolsky; H-J Oestern; H Palm; J B Sintenie; R Komadina; C Copuroglu
Journal:  Eur J Trauma Emerg Surg       Date:  2016-08       Impact factor: 3.693

Review 4.  A systematic review of undisplaced femoral neck fracture treatments for patients over 65 years of age, with a focus on union rates and avascular necrosis.

Authors:  Dan-Feng Xu; Fang-Gang Bi; Chi-Yuan Ma; Zheng-Fa Wen; Xun-Zi Cai
Journal:  J Orthop Surg Res       Date:  2017-02-10       Impact factor: 2.359

5.  Palliative Management of Nonoperative Femoral Neck Fractures With Continuous Peripheral Indwelling Catheters: Case-Control Series.

Authors:  Christopher H Rashidifard; Nicholas Romeo; Mark Richardson; Paul Muccino; Thomas DiPasquale; Chelsea M Bush
Journal:  Geriatr Orthop Surg Rehabil       Date:  2019-03-11

6.  Challenging the dogma to "always operate" acute hip fractures: a proof-of-concept pilot study for nonoperative management of undisplaced femoral neck fractures.

Authors:  Juan Manuel Vinas-Rios; Jan-Henning Wölm; Richard Martin Sellei; Andreas Ladenburger
Journal:  Patient Saf Surg       Date:  2022-04-21

7.  Conservative versus surgical treatment for Garden I hip fracture: A randomized controlled trial protocol.

Authors:  Wei Wang; Fangzhu Xu; Jianguang Luo; Liping Zhu
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.